There were 682 press releases posted in the last 24 hours and 150,796 in the last 365 days.

Detailed Research: Economic Perspectives on Graco, Immunomedics, Concert Pharmaceuticals, Macquarie Infrastructure, Systemax, and Service Corporation International — What Drives Growth in Today's Competitive Landscape

NEW YORK, Oct. 12, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Graco Inc. (NYSE:GGG), Immunomedics, Inc. (NASDAQ:IMMU), Concert Pharmaceuticals, Inc. (NASDAQ:CNCE), Macquarie Infrastructure Company (NYSE:MIC), Systemax Inc. (NYSE:SYX), and Service Corporation International (NYSE:SCI), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

/EIN News/ -- Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

GGG DOWNLOAD: http://MarketSourceResearch.com/register/?so=GGG
IMMU DOWNLOAD: http://MarketSourceResearch.com/register/?so=IMMU
CNCE DOWNLOAD: http://MarketSourceResearch.com/register/?so=CNCE
MIC DOWNLOAD: http://MarketSourceResearch.com/register/?so=MIC
SYX DOWNLOAD: http://MarketSourceResearch.com/register/?so=SYX
SCI DOWNLOAD: http://MarketSourceResearch.com/register/?so=SCI

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine Graco Inc. (NYSE:GGG), Immunomedics, Inc. (NASDAQ:IMMU), Concert Pharmaceuticals, Inc. (NASDAQ:CNCE), Macquarie Infrastructure Company (NYSE:MIC), Systemax Inc. (NYSE:SYX), and Service Corporation International (NYSE:SCI) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed October 10th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

GRACO INC. (GGG) REPORT OVERVIEW

Graco's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Graco reported revenue of $424.57MM vs $379.48MM (up 11.88%) and analysts estimated basic earnings per share $0.53 vs $0.48 (up 10.42%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Graco reported revenue of $1,474.74MM vs $1,329.29MM (up 10.94%) and analysts estimated basic earnings per share $1.50 vs $0.24 (up 525.00%). Analysts expect earnings to be released on October 24th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.38. The estimated EPS forecast for the next fiscal year is $1.98 and is expected to report on February 4th, 2019.

To read the full Graco Inc. (GGG) report, download it here: http://MarketSourceResearch.com/register/?so=GGG

-----------------------------------------

IMMUNOMEDICS, INC. (IMMU) REPORT OVERVIEW

Immunomedics' Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Immunomedics reported revenue of $0.39MM vs $0.64MM (down 39.86%) and analysts estimated basic earnings per share -$0.58 vs -$0.52. For the twelve months ended June 30th, 2018 vs June 30th, 2017, Immunomedics reported revenue of $2.16MM vs $3.09MM (down 30.26%) and analysts estimated basic earnings per share -$1.78 vs -$1.47. Analysts expect earnings to be released on November 8th, 2018. The report will be for the fiscal period ending September 30th, 2018. Reported EPS for the same quarter last year was -$0.16. The estimated EPS forecast for the next fiscal year is -$0.84 and is expected to report on August 22nd, 2019.

To read the full Immunomedics, Inc. (IMMU) report, download it here: http://MarketSourceResearch.com/register/?so=IMMU

-----------------------------------------

CONCERT PHARMACEUTICALS, INC. (CNCE) REPORT OVERVIEW

Concert Pharmaceuticals' Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Concert Pharmaceuticals reported revenue of $0.00MM vs $0.02MM and analysts estimated basic earnings per share -$0.57 vs -$0.58. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Concert Pharmaceuticals reported revenue of $143.89MM vs $0.17MM (up 82,595.98%) and analysts estimated basic earnings per share $4.20 vs -$2.28. Analysts expect earnings to be released on November 8th, 2018. The report will be for the fiscal period ending September 30th, 2018. Reported EPS for the same quarter last year was -$0.70. The estimated EPS forecast for the next fiscal year is -$2.75 and is expected to report on March 7th, 2019.

To read the full Concert Pharmaceuticals, Inc. (CNCE) report, download it here: http://MarketSourceResearch.com/register/?so=CNCE

-----------------------------------------

MACQUARIE INFRASTRUCTURE COMPANY (MIC) REPORT OVERVIEW

Macquarie Infrastructure's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Macquarie Infrastructure reported revenue of $478.08MM vs $438.99MM (up 8.90%) and basic earnings per share $0.45 vs $0.32 (up 40.63%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Macquarie Infrastructure reported revenue of $1,814.71MM vs $1,651.73MM (up 9.87%) and analysts estimated basic earnings per share $5.42 vs $1.93 (up 180.83%). Analysts expect earnings to be released on November 7th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.48. The estimated EPS forecast for the next fiscal year is $2.89 and is expected to report on February 20th, 2019.

To read the full Macquarie Infrastructure Company (MIC) report, download it here: http://MarketSourceResearch.com/register/?so=MIC

-----------------------------------------

SYSTEMAX INC. (SYX) REPORT OVERVIEW

Systemax's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Systemax reported revenue of $363.10MM vs $313.00MM (up 16.01%) and analysts estimated basic earnings per share $0.49 vs $0.37 (up 32.43%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Systemax reported revenue of $1,265.40MM vs $1,170.30MM (up 8.13%) and analysts estimated basic earnings per share $1.09 vs -$0.88. Analysts expect earnings to be released on October 30th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.32. The estimated EPS forecast for the next fiscal year is $1.43 and is expected to report on February 26th, 2019.

To read the full Systemax Inc. (SYX) report, download it here: http://MarketSourceResearch.com/register/?so=SYX

-----------------------------------------

SERVICE CORPORATION INTERNATIONAL (SCI) REPORT OVERVIEW

Service Corporation International's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Service Corporation International reported revenue of $796.09MM vs $773.24MM (up 2.96%) and analysts estimated basic earnings per share $0.57 vs $0.37 (up 54.05%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Service Corporation International reported revenue of $3,095.03MM vs $3,031.14MM (up 2.11%) and analysts estimated basic earnings per share $2.91 vs $0.92 (up 216.30%). Analysts expect earnings to be released on October 24th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.33. The estimated EPS forecast for the next fiscal year is $2.00 and is expected to report on February 12th, 2019.

To read the full Service Corporation International (SCI) report, download it here: http://MarketSourceResearch.com/register/?so=SCI

-----------------------------------------

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Hugo Moreau, Media Department
Office: +1 (704) 343-6361
E-mail: media@MarketSourceResearch.com

© 2018 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Distribution channels:


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.